Intelligence Β· Patent portfolio
Disc Medicine Patents
Full USPTO pharma patent portfolio for Disc Medicine β grant dates, expiration, and drug cross-links.
- Patents
- 706
- Expiring β€24m
- 26
Quick answer
Disc Medicine has 706 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 26 expire within 24 months β use filters for patent-cliff planning.
-
US 6884618
Identification of the gene causing the mouse scurfy phenotype and its human ortholog
expired -
US 6878709
3,4-di-substituted pyridazinediones as CXC chemokine receptor antagonists
expired -
US 6864263
N-heterocyclic derivatives as NOS inhibitors
expired -
US 6864368
N-heterocyclic derivatives as NOS inhibitors
expired -
US 6849621
Piperidine compounds
expired -
US 6849739
N-heterocyclic derivatives as NOS inhibitors
expired -
US 6846829
N-heterocyclic derivatives as NOS inhibitors
expired -
US 6841674
N-heterocyclic derivatives as NOS inhibitors
expired -
US 6818622
Selective MMP inhibitors having reduced side-effects
expired -
US 6809100
Hydroxamic acid derivatives
expired -
US 6803453
Antibodies associated with alterations in bone density
expired -
US 6794145
Identification of the gene causing the mouse scurfy phenotype and its human ortholog
expired -
US 6787573
Antiviral therapy
expired -
US 6787536
Hydroxamic acid derivatives
expired -
US 6734189
Hydroxamic and carboxylic acid derivatives
expired -
US 6730794
Substituted indolealkanoic acids
expired -
US 6706257
Sunless tanning products and processes
expired -
US 6706719
Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity
expired -
US 6683160
Antibodies specific for Fkhsf gene products
expired -
US 6683171
Identification of the gene causing the mouse scurfy phenotype and its human ortholog
expired -
US 6667162
Identification of the gene causing the mouse scurfy phenotype and its human ortholog
expired -
US 6624140
Synthetic peptides with antimicrobial and endotoxin neutralizing properties for management of the sepsis syndrome
expired -
US 6555127
Multi-spike release formulation for oral drug delivery
expired -
US 6555568
Methods of reducing serum glucose and triglyceride levels and for inhibiting angiogenesis using substituted indolealkanoic acids
expired -
US 6521659
Compositions containing a substituted indolealkanoic acid and an angiotensin converting enzyme inhibitor
expired -
US 6514994
Levobupivacaine and its use
expired -
US 6506773
Hydroxamic and carboxylic acid derivatives
expired -
US 6506764
Hydroxamic and carboxylic acid derivatives
expired -
US 6503910
Hydroxamic and carboxylic acid derivatives
expired -
US 6495736
Compositions and methods for increasing bone mineralization
expired -
US 6482440
Long acting antidepressant microparticles
expired -
US 6469020
Hydroxamic and carboxylic acid derivatives
expired -
US 6465468
Hydroxamic and carboxylic acid derivatives
expired -
US 6462042
Hydroxamic acid derivatives as matrix metalloproteinase (mmp) inhibitors
expired -
US 6455561
Heterocyclic compounds and their therapeutic use
expired -
US 6455531
Hydroxamic acid derivatives
expired -
US 6444226
Purification and stabilization of peptide and protein pharmaceutical agents
expired -
US 6440463
Methods for fine powder formation
expired -
US 6428771
Method for drug delivery to the pulmonary system
expired -
US 6426344
Aryl and heteroaryl substituted indolealkanoic acids
expired -
US 6420426
Substituted phenoxyacetic acids
expired -
US 6417201
Levobupivacaine as an analgesic agent
expired -
US 6417010
Methods and apparatus for synthesizing labeled combinatorial chemistry libraries
expired -
US 6414129
Identification of the gene causing the mouse scurfy phenotype and its human ortholog
expired -
US 6403791
Heterocyclic compounds and their therapeutic use
expired -
US 6395511
Nucleic acids encoding a novel family of TGF-&bgr; binding proteins from humans
expired -
US 6387959
Antiviral therapy
expired -
US 6387686
Methods and compositions for identifying a polynucleotide encoding a protease
expired
Frequently asked questions
How many patents does Disc Medicine have?
706 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Disc Medicine patents expire?
26 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.
Where does this data come from?
USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.
Data attribution: Data sources Β· Patent directory